What it is
SNAP-8 is a synthetic peptide — a short chain of amino acids, the building blocks of protein. Its chemical name is acetyl octapeptide-3; "octa" means eight, which is how many amino acids it has.
It is described as mimicking the effects of Botox. What that means is worth unpacking. Facial expression lines form because muscles contract, and they contract when a nerve releases a chemical messenger called acetylcholine. SNAP-8 interferes with that release. Less signal reaching the muscle means the muscle relaxes, and a relaxed muscle does not crease the skin above it.
The difference from Botox is that SNAP-8 is not injected. It goes on the skin.
Alongside the muscle-relaxing effect, SNAP-8 is said to promote collagen production, improve skin elasticity, and hydrate and nourish the skin.
It arrives as a dry powder in a sealed glass vial. You mix it with a small amount of bacteriostatic water — sterile water with a preservative so it keeps — and then stir the whole thing into a cream or serum, which is what you actually put on your face. This is for the skin only. It is not injected.
Acetyl octapeptide-3, an eight-residue synthetic peptide. Functionally a neurotransmitter-inhibiting peptide of the same family as acetyl hexapeptide-8 (Argireline), which is listed as a complementary ingredient.
Stated mechanism: inhibition of acetylcholine, reducing the neurotransmitter signal reaching facial muscles and relaxing them, thereby reducing expression lines and wrinkles. The proposed molecular target for this class is the SNARE complex assembly required for vesicular acetylcholine release at the neuromuscular junction — which is also botulinum toxin's target, hence the Botox comparison.
Secondary claimed activity: collagen synthesis promotion, improved skin elasticity, hydration, and nourishment.
Supplied as lyophilised powder. Reconstituted in a very small diluent volume and then incorporated into a cosmetic base. Topical administration only.
Clinical trials are cited as showing average wrinkle reduction of 30–68% after one month of twice-daily use. No citation, sample size, method, or measurement basis is available for that figure.
What it does
The main effect is on expression lines — the lines that form where you repeatedly move your face. Around the eyes, the mouth, and the forehead. By reducing the nerve signals that make those muscles contract, it lets the muscles relax and the lines soften.
It also fills in fine lines and wrinkles, and is said to restore the body's ability to produce collagen and elastin — the two proteins that give skin its structure and its stretch.
It hydrates the skin.
And it strengthens the skin barrier, which is the skin's outer defence against bacteria, pollution, toxins, and ultraviolet rays.
Clinical trials are cited as showing an average wrinkle reduction of 30% to 68% after one month of twice-daily use. Which trials, how many people, and how the wrinkles were measured has not been published.
Primary effect: reduction of dynamic expression lines periorbitally, perioral, and on the forehead, via reduced cholinergic signalling to the underlying mimetic musculature.
Secondary effects claimed: filling of fine lines and wrinkles; restoration of collagen and elastin production; hydration; and barrier strengthening against bacteria, pollution, toxins, and UV.
Efficacy claim: average wrinkle reduction of 30–68% after one month of twice-daily application, per unspecified clinical trials. The range is wide enough, and the citation absent enough, that it should be read as a marketing figure rather than a result.
It is positioned as a safe, non-invasive alternative to cosmetic procedures, and as providing long-lasting anti-ageing benefit — with no definition of "long-lasting" and no discussion of how the effect decays after discontinuation.
Benefits
Evidence grades: what the labels mean
- Human trials Supported by randomised or placebo-controlled human trials.
- Limited human data Some human evidence, such as pilot studies, case reports or observational data, but no controlled trials.
- Animal or lab only Shown in animal or cell studies only; not yet tested in people.
- Anecdotal No published studies; based on user reports or theory.
Each grade reflects the strongest published support for that specific claim, not for the compound as a whole.
- Reduces the appearance of expression lines around the eyes, mouth, and forehead.Limited human data
- Fills in fine lines and wrinkles.Anecdotal
- Provides long-lasting anti-ageing benefits.Anecdotal
- Hydrates the skin.Anecdotal
- A safe and non-invasive alternative to cosmetic procedures.Anecdotal
- Strengthens the skin barrier, protecting against bacteria, pollution, toxins, and ultraviolet rays.Anecdotal
- Restores the body's ability to produce collagen and elastin, the proteins that give skin structure and stretch.Anecdotal
- Cited clinical trials showed an average wrinkle reduction of 30% to 68% after one month of twice-daily use. Which trials, and how the measurement was made, has not been published.Limited human data
- Reduction of expression lines periorbitally, perioral, and on the forehead.Limited human data
- Filling of fine lines and wrinkles.Anecdotal
- Long-lasting anti-ageing benefit — undefined, with no discussion of effect decay after discontinuation.Anecdotal
- Skin hydration.Anecdotal
- Positioned as a safe, non-invasive alternative to cosmetic procedures.Anecdotal
- Barrier strengthening against bacterial, pollutant, toxin, and UV challenge.Anecdotal
- Restoration of collagen and elastin production.Anecdotal
- Cited trials: average wrinkle reduction of 30–68% after one month of twice-daily use. No citation, cohort size, measurement method, or control is given, and the range spans more than a factor of two.Limited human data
Reconstitution and dosing
Topical only. This is not injected. The lotion goes on the skin.
Step one: dissolve the powder. The vial holds 10 milligrams. Inject 0.3 to 0.5 mL (milliliters; 30 to 50 units on an insulin syringe) of bacteriostatic water slowly into the vial. Gently roll it between your palms to mix — do not shake it. Because the volume of water is so small, let the vial sit for 10 to 20 minutes so the powder fully dissolves.
Step two: get it out of the vial. If it is hard to draw up with a syringe, use a large blue reconstitution syringe or a 100-unit syringe and go slowly. Alternatively, take the cap off the vial and simply pour the contents into your skincare base.
Step three: mix it in. Add the entire vial to at most 1 ounce of skincare cream or serum. A smaller amount of base makes a stronger mixture, which is also more likely to irritate.
Step four: use it. Apply once in the morning and once in the evening. Twice-daily use for a month is the schedule the cited wrinkle-reduction figures come from.
Before you mix the full vial, if your base contains retinol or vitamin C, do a patch test first. Those two are the combinations flagged for irritation.
About the table below. There is no dose in micrograms here, because the product is not dosed that way. What you control is how much base you mix one 10 mg vial into, and then you apply the resulting cream twice a day. No quantity per application has been specified.
Topical administration only.
Reconstitution. 10 mg vial with 0.3–0.5 mL (30–50 units) of bacteriostatic water, injected slowly into the vial. Gentle rolling between the palms to mix; no shaking. The diluent volume is small enough that a 10–20 minute dissolution stand is specified.
Extraction. If syringe withdrawal is difficult at that volume — it will be — use a large-bore reconstitution syringe or a 100-unit syringe drawn slowly. The alternative is removing the vial cap and decanting directly into the base.
Incorporation. The entire vial into a maximum of 1 ounce of cosmetic cream or serum. Note the direction of that constraint: one ounce is the ceiling on base volume and therefore the floor on final concentration. At 10 mg in 1 oz (≈29.6 mL) the working concentration is roughly 0.034% — below the 0.05% and higher concentrations these peptides are typically formulated at commercially. Reducing the base volume raises concentration and, per the adverse-effect entry above, raises irritation risk.
Application. Once morning, once evening. The cited 30–68% wrinkle reduction figure is attached specifically to one month of twice-daily use.
Compatibility testing. Patch test mandated before incorporating a full vial into any base containing retinoids or vitamin C.
On the absence of a per-application dose. Vial mass and maximum base volume are specified, and nothing about quantity applied per use. There is consequently no microgram-per-application figure to compute, and none is given below. The controllable variable is base volume.
10 mg vial, dispersed into a skincare base
Reconstitute the 10 mg vial with 0.3–0.5 mL (30–50 units) of bacteriostatic water, roll gently, and let it stand 10–20 minutes to dissolve fully. Then add the entire vial to a maximum of 1 ounce of cream or serum — a smaller base volume makes a stronger and more irritating mixture. Patch test first if the base contains retinol or vitamin C.
Cycle: No cycle or washout has been established. The cited wrinkle-reduction figures come from one month of twice-daily use · Frequency: Twice daily, morning and evening; topical only, never injected
| When | Dose | How often |
|---|---|---|
| Morning | Apply the blended cream or serum once. No quantity per application has been specified — the whole 10 mg vial goes into up to 1 ounce of base | 1×/day |
| Evening | Apply the blended cream or serum once | 1×/day |
Who should avoid it
- No contraindications have been documented for SNAP-8 — there is no "do not use if" guidance and no groups of people it excludes. What does exist is a list of things not to combine it with, below.
- Do not use it with strong exfoliants — AHAs and BHAs, the acid exfoliants found in many skincare products.
- Do not use it with products that have a high pH.
- Do not use it with vitamin A-based products.
- Use caution with retinol. It is flagged as potentially irritating when combined at high concentrations, so do a patch test first.
- Use caution with vitamin C. Same warning: potentially irritating at high concentrations, patch test first.
- The instruction on those last two is specific — always perform a patch test with SNAP-8 when using it alongside retinoids or vitamin C, to check for irritation before mixing a full vial into your base.
- No guidance on pregnancy or breastfeeding is available, in either direction.
- No allergy or hypersensitivity warning has been documented, which is unusual — almost every other page on this site carries one.
- Retinol is a vitamin A derivative, yet the guidance above says both not to use vitamin A-based products at all while also listing retinol as a complementary ingredient requiring only a patch test. Those two instructions conflict. The conservative reading is the outright prohibition.
- SNAP-8 is topical only, but it arrives in a peptide vial reconstituted with bacteriostatic water like an injectable. Do not inject it.
- No contraindications have been documented — no excluded populations, no medical conditions, no hypersensitivity warning. What exists instead is a formulation incompatibility list.
- Do not combine with strong exfoliants — AHAs, BHAs.
- Do not combine with high-pH products. Peptide stability is pH-dependent, though the mechanism has not been specified.
- Do not combine with vitamin A-based products.
- Caution with retinol: potential irritation at high concentration; patch test mandated before mixing a full vial.
- Caution with vitamin C: potential irritation at high concentration; patch test mandated before mixing a full vial.
- Pregnancy and lactation are unaddressed.
- No hypersensitivity or allergy warning has been documented, which is anomalous against every other page on this site.
- Retinol is listed among complementary ingredients subject to a patch test, while vitamin A-based products are separately prohibited outright. Retinol is a vitamin A derivative. The prohibition and the conditional permission are not reconciled; the prohibition is the conservative reading.
- The product ships as a lyophilised peptide vial reconstituted with bacteriostatic water, which is the presentation of an injectable on every other page here. The route is topical only, but the presentation invites the error.
Side effects
- SNAP-8 is generally well tolerated.
- Mild irritation may occur, especially at higher concentrations or when mixed with retinoids or vitamin C.
- Redness may occur, under the same conditions.
- That is the complete documented list — two effects and a tolerability statement.
- The irritation entry is conditional on concentration, which is directly under your control here, since you decide how much base to mix the vial into. A full 10 mg vial in half an ounce of cream is twice the concentration of the same vial in a full ounce.
- No advice is available about what to do if irritation appears — whether to stop, dilute further, or reduce frequency.
- SNAP-8 is characterised as generally well tolerated.
- Mild irritation, particularly at higher concentrations or in combination with retinoids or vitamin C.
- Erythema, under the same conditions.
- That is the complete documented adverse effect profile.
- Concentration is user-determined here — the same 10 mg vial dispersed into half an ounce versus a full ounce of base differs twofold in final concentration, and the maximum-of-one-ounce instruction sets a floor on concentration, not a ceiling.
- No management guidance is available for irritation — no dilution, frequency reduction, or discontinuation advice.
- No systemic adverse effects are described, which is consistent with a topical peptide of this size but is asserted rather than demonstrated.
User reports
User reports are individual experiences submitted by site visitors. They are not medical advice, are not verified for accuracy, and do not reflect Amino Reference's views. Read the evidence section above and talk to a clinician. Full disclaimer.
Stacking
Named both as a complementary skincare ingredient and as a stack: it regenerates skin tissue and boosts collagen and elastin. The GHK-Cu page on this site covers topical use as well as injection, and notes that topical use has no reported side effects.
Listed twice — among compatible skincare ingredients as "GHK-Cu or other topical copper peptides", and in the stacking section for tissue regeneration and collagen and elastin support. Mechanistically complementary rather than overlapping: SNAP-8 acts on neuromuscular signalling, GHK-Cu on matrix remodelling. The GHK-Cu page documents topical administration with no reported adverse effects.
- Argireline (acetyl hexapeptide-8)
It works synergistically with SNAP-8 to further reduce expression lines. It is the closest relative of SNAP-8 — a six-amino-acid peptide working the same way.
Same mechanistic class — acetyl hexapeptide-8, the six-residue neurotransmitter-inhibiting peptide. Claimed synergy on expression lines. Combining two agents with the same target is additive rather than synergistic in the strict sense, and the claim does not distinguish.
- Leuphasyl
It complements SNAP-8 by relaxing facial tension and smoothing deep wrinkles.
Suggested for complementary relaxation of facial tension and smoothing of deep wrinkles. A third neuropeptide-class agent, acting presynaptically by a different route than the SNARE-targeting peptides.
- Matrixyl 3000
Used for improving skin firmness and elasticity over time.
Suggested for firmness and elasticity over time. A matrix-signalling peptide complex rather than a neuromodulatory one, so non-overlapping with SNAP-8's mechanism.
- Hyaluronic acid
Suggested for deep hydration that plumps the skin and helps SNAP-8 absorb.
Suggested for deep hydration, plumping, and enhanced absorption. Also named among compatible base ingredients, making it a reasonable default for the carrier as well as an additive.
- Niacinamide
Used for brightening skin tone, reducing pore size, and strengthening the skin barrier.
Suggested for brightening, pore size reduction, barrier strengthening. Listed both as a compatible base ingredient and as a stack.
Dosing figures have been reviewed and units are recomputed from the stated protocol.